‘Inactive’ drug ingredients are not always inactive, study finds
The label on a pill bottle lists the drug’s active and inactive ingredients, but new research concludes some “inactive” ingredients aren’t so inactive. More
Don’t Hype the Hope for Oxford-AstraZeneca Covid Vaccine
There's cause for optimism, but the race still has miles to go. More
Family doctor, employer groups join forces to replace fee-for-service
The American Academy of Family Physicians and National Alliance of Healthcare Purchaser Coalitions look to scale a care model that aims to shift away from fee-for-service reimbursement. More
Covid-19: an opportunity to reduce unnecessary healthcare
The continuing costs of the pandemic combined with the impending financial crisis will inevitably mean having to do more with less. More
U.S. Hospitals Need to Study How Well Remdesivir Really Works
With only limited evidence of effectiveness, the drug should be put to a large clinical trial. More
Amid Surge, Hospitals Hesitate To Cancel Nonemergency Surgeries
Unlike earlier in the year, most hospitals are not proactively canceling elective surgeries, even in some places seeing spikes in coronavirus patients. More
Proposed changes to lung cancer screening guidance could increase scans among Black patients, women
Proposed changes to lung cancer screening guidelines would could lead to more Black patients and women eligible for potentially life-saving scans. More
Slow Medicine: COVID-19 Exposes What’s Wrong With U.S. Healthcare
Nations that effectively implemented simple public health measures have fared much better. More
COVID-19: A Boost for Capitated Payment Models
They can provide a steady income even in 'down' times More
An experiment in end-of-life care: Tapping AI’s cold calculus to nudge the most human of conversations
A handful of hospitals and cancer clinics are tapping the cold calculations of AI to nudge conversations around some of the most deeply human questions. More